Dalla-Bona, A. C., K. Stoisiek, N. Oesterheld, T. Schmehl, T. Gessler, W. Seeger and M. Beck-Broichsitter: Characterization of lung-delivered in-situ forming controlled release formulations. In: J Pharm Pharmacol 67, 10, 1349-1354 (2015).
url: http://www.ncbi.nlm.nih.gov/pubmed/25920623
Dalla-Bona, A. C., T. Schmehl, T. Gessler, W. Seeger and M. Beck-Broichsitter: Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance. In: Drug Dev Ind Pharm 41, 10, 1704-1709 (2015).
url: http://www.ncbi.nlm.nih.gov/pubmed/25519975
Dalla-Bona, A. C., T. Schmehl, T. Gessler, W. Seeger and M. Beck-Broichsitter: Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance. In: Drug Dev Ind Pharm, 1-6 (2014).
url: http://www.ncbi.nlm.nih.gov/pubmed/25519975
Herold, S., K. Hoegner, I. Vadasz, T. Gessler, J. Wilhelm, K. Mayer, R. E. Morty, H. D. Walmrath, W. Seeger and J. Lohmeyer: Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome. In: Am J Respir Crit Care Med 189, 5, 609-611 (2014).
url: http://www.ncbi.nlm.nih.gov/pubmed/24579839
Beck-Broichsitter, M., M. Rieger, R. Reul, T. Gessler, W. Seeger and T. Schmehl: Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations. 84, 1, 106-114 (2013).
url: http://www.ncbi.nlm.nih.gov/pubmed/23262166
Beck-Broichsitter, M., J. Gauss, T. Gessler, W. Seeger, T. Kissel and T. Schmehl: Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles. In: J Aerosol Med Pulm Drug Deliv 23, 1, 47-57 (2010).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19778266
Kleemann, E., N. Jekel, L. A. Dailey, S. Roesler, L. Fink, N. Weissmann, R. Schermuly, T. Gessler, T. Schmehl, C. J. Roberts, W. Seeger and T. Kissel: Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery. In: J Drug Target 17, 8, 638-51 (2009).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19589123
Voswinckel, R., F. Reichenberger, H. Gall, T. Schmehl, T. Gessler, R. T. Schermuly, F. Grimminger, L. J. Rubin, W. Seeger, H. A. Ghofrani and H. Olschewski: Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension. In: Pulm Pharmacol Ther 22, 1, 50-6 (2009).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19071225
Nguyen, J., R. Reul, T. Betz, E. Dayyoub, T. Schmehl, T. Gessler, U. Bakowsky, W. Seeger and T. Kissel: Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells. In: J Control Release 140, 1, 47-54 (2009).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19666064
Beck-Broichsitter, M., J. Gauss, C. B. Packhaeuser, K. Lahnstein, T. Schmehl, W. Seeger, T. Kissel and T. Gessler: Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. In: Int J Pharm 367, 1-2, 169-78 (2009).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18848609
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.